Lecture Theatre 003
-
International
Discover moreBusiness
Northumbria University is proud to offer a range of Professional, Statutory and Regulatory Body (PSRB) approved & accredited courses and programmes. Explore our list of courses and programmes under our Education and Training page.
Discover moreResearch
Northumbria is a research-rich, business-focused, professional university with a global reputation for academic quality. We conduct ground-breaking research that is responsive to the science & technology, health & well being, economic and social and arts & cultural needs for the communities
Discover moreAlumni
Northumbria University is renowned for the calibre of its business-ready graduates. Our alumni network has over 253,000 graduates based in 178 countries worldwide in a range of sectors, our alumni are making a real impact on the world.
Discover moreLecture Theatre 003
-
B cells are an essential part of our adaptive immune system and are responsible for the production of antibodies. These Y-shaped molecules can specifically recognize foreign invaders (e.g. SARS-CoV-2) and prevent their entry into the body.
Shortly after infection or vaccination, B cells with the appropriate specificity become activated and can rapidly produce large quantities of antibodies directed against the offending agent. However, over time the levels of specific antibodies in the body can drop below protective levels. Fortunately, some of the B cells become long-lived memory cells and can rapidly be reawakened to produce protective antibodies once more, even against newer versions of virus.
In a fascinating lecture, Professor Greg Kirchenbaum will discuss his current research focusing on the detection of such specific memory B cells in the blood using a technique called ImmunoSpot. He will explain how detection of memory B cells using the ImmunoSpot technique promises to offer insights that measurements of antibody levels in blood cannot.
About the Speaker
Professor Greg Kirchenbaum is Director of B cell Research, Cellular Technology Ltd, Cleveland, Ohio, USA. He received his BSc honours from Florida State University in Biology and went on to the prestigious Immunology Department at the University of Colorado to work on his PhD in the area of B cell tolerance with Lawrence Wysocki. Post-doctoral fellowships at the Vaccine and Gene Therapy Institute of Florida, and Center for Vaccines and Immunology, University of Georgia, followed, where he worked with Ted Ross.
In 2018 Professor Kirchenbaum joined Cellular Technology Ltd (CTL) in Cleveland, Ohio, to work with Professor Paul V. Lehmann MD/PhD, where he is now Director of B cell research. He has been instrumental in developing the B cell ImmunoSpot assay platform at CTL. B cell and antibody responses have been a constant theme in his career, and he has over 40 publications in prestigious journals and given numerous keynote presentations. He has a close collaboration with Professor Stephen Todryk at Northumbria University, where they co-supervise a PhD student.
-
Events
A Northumbria University graduate who turned his love of cricket into a social enterprise supporting…
Researchers at Northumbria University, Newcastle University, and the University of Glasgow…
A Northumbria University-backed programme giving North-East pupils the chance to do real space…
An international team led by Northumbria University has developed and validated a simple five-factor…
A new national network led by Newcastle University and Northumbria University, in partnership…
A Northumbria University criminologist has been awarded a Philip Leverhulme Prize, one of the…
Pioneering data platform maps where the Armed Forces community receive support from charities
A major study co-led by Northumbria University will test whether attachment assessments lead…
Sutherland Building
Northumbria University
-
Durrant Hall
-
Lecture Theatre 003, Business & Law Building
-